MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Edwards lands four-year $500 million revolving credit facility | Funding Roundup

Edwards lands four-year $500 million revolving credit facility | Funding Roundup

By

Edwards Lifesciences

Edwards Lifesciences Corp. (NYSE:EW) landed a new four-year $500 million credit facility after canceling a prior one a couple months early.

The old facility was a five-year deal, also for $500 million, that was scheduled to mature September 29, 2011.

Under the new agreement, Edwards, which ranked 46th on the MassDevice Big 100 list of the world’s largest medical device companies, is eligible to increase its facility up to another $250 million, subject to certain terms and conditions.

Funding

Here’s a roundup of other dealflow and investment news:

  • Knome raises $5 million for gene sequencing
    Cambridge, Mass.-based Knome Inc. raised $5 million of a $20 million equity funding round that began mid-July. The $5 million came from one unnamed investor, filings show.
    Read more

  • Cardia touts closes $2 million round
    Minnesota-based Cardia Inc., maker of cardiac implants for treatment of congenital heart defects, closed a $2 million funding round spread across 24 investors.
    Read more

  • NeoChord pulls in nearly half of a $11 million round
    Minnesota-based biotech firm NeoChord Inc. raised just over $5 million of a $11 million series B preferred stock and warrant round, gathered from 44 investors. NeoChord makes a minimally invasive implant for patients with ruptured or elongated mitral valves.
    Read more

  • Restoration Robotics touts $41 million for hair restoration
    Restoration Robotics Inc. landed $41 million through a series C financing round. Investment in the physician-controlled, computer-aided hair restoration robotics company was led by Clarus Ventures, and joined by Sutter Hill Ventures, Alloy Ventures and Interwest Partners.
    Read more

  • Vessix Vascular closes a $23 million round
    Laguna Hills, Calif.-based radiofrequency catheter maker Vessix Vascular Inc. closed a $23 million series B preferred stock financing round led by Edmond de Rothschild Investment Partners. The company plans to use the funds as working capital to accelerate development initiatives and to fund clinical trials to expand clinical indications for its RF balloon catheter technology.
    Read more

  • Abaxis repurchases stock
    Abaxis Inc.’s (NSDQ:ABAX) board of directors approved a $40 million common stock repurchase program, to be made from time to time on the open market.
    Read more

  • Acutus Medical wins $1 million from private investors
    San Diego, Calif.-based Acutus Medical Inc. landed a $1 million investment from private investors, including Index Ventures. The company develops electrophysiological mapping technology for treatment of cardiac arrhythmias.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]

Leave a Reply